Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema ADVICENNE

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
28.03.Advicenne: Strong improvement of 2023 results thanks to sustained commercial activity on Sibnayal289Sibnayal volume up 84%. Gross sales exceed €4 million for the first time. Sharp decrease in net loss to -7.03 M€ vs. -11.47 M€ in 2022. Year-end cash position at €5.25 million...
► Artikel lesen
25.03.Advicenne: FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.316After distal Renal Tubular Acidosis (dRTA) in December 2022, ADV7103 is granted "orphan drug" status in the United States in cystinuria. A long-awaited milestone for the Company and its flagship...
► Artikel lesen
23.01.Advicenne Reports 2023 Gross Sales1 up 20% to €4.43 Million256PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative...
► Artikel lesen
28.12.23Advicenne Announces Its 2024 Financial Calendar380Regulatory News: Advicenne(Euronext Growth Paris ALDVI FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering...
► Artikel lesen